These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24465937)

  • 1. Genetic instability persists in non-neoplastic urothelial cells from patients with a history of urothelial cell carcinoma.
    de Castro Marcondes JP; de Oliveira ML; Gontijo AM; de Camargo JL; Salvadori DM
    PLoS One; 2014; 9(1):e86162. PubMed ID: 24465937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma.
    Gontijo AM; Marcondes JP; Elias FN; de Oliveira ML; de Lima RO; Salvadori DM; de Camargo JL
    Environ Mol Mutagen; 2002; 40(3):190-9. PubMed ID: 12355553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequencies of micronuclei, nucleoplasmic bridges and nuclear buds as biomarkers of genomic instability in patients with urothelial cell carcinoma.
    Podrimaj-Bytyqi A; Borovečki A; Selimi Q; Manxhuka-Kerliu S; Gashi G; Elezaj IR
    Sci Rep; 2018 Dec; 8(1):17873. PubMed ID: 30552338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
    Wang SS; Liu YF; Ou YC; Chen CS; Li JR; Yang SF
    PLoS One; 2013; 8(12):e82804. PubMed ID: 24349364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
    Li CC; Hsieh MJ; Wang SS; Hung SC; Lin CY; Kuo CW; Yang SF; Chou YE
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosis.
    Espinoza F; Cecchini L; Morote J; Marcos R; Pastor S
    Environ Mol Mutagen; 2019 Mar; 60(2):168-173. PubMed ID: 30284731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging.
    Schreiber H; Hänze J; Nimphius W; Verburg FA; Luster M; Hofmann R; Hegele A
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):305-313. PubMed ID: 31897687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
    Brait M; Munari E; LeBron C; Noordhuis MG; Begum S; Michailidi C; Gonzalez-Roibon N; Maldonado L; Sen T; Guerrero-Preston R; Cope L; Parrella P; Fazio VM; Ha PK; Netto GJ; Sidransky D; Hoque MO
    Cell Cycle; 2013 Apr; 12(7):1058-70. PubMed ID: 23435205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.
    Sasaki Y; Sasaki T; Kawai T; Morikawa T; Matsusaka K; Kunita A; Kume H; Aoki I; Homma Y; Fukayama M
    Int J Clin Exp Pathol; 2014; 7(2):699-708. PubMed ID: 24551292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
    Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE
    Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of
    Hung SC; Wang SS; Li JR; Chen CS; Yang CK; Chiu KY; Cheng CL; Ou YC; Ho HC; Yang SF
    Int J Med Sci; 2018; 15(14):1731-1736. PubMed ID: 30588197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.
    Chekaluk Y; Wu CL; Rosenberg J; Riester M; Dai Q; Lin S; Guo Y; McDougal WS; Kwiatkowski DJ
    PLoS One; 2013; 8(4):e60927. PubMed ID: 23593348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Expression of miR-182 in Cytology Specimens of High-Grade Urothelial Cell Carcinoma: A Potential Diagnostic Marker.
    Wei S; Bing Z; Yao Y; Master SR; Gupta P
    Acta Cytol; 2015; 59(1):109-12. PubMed ID: 25676538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
    Fan M; Zhuang Q; Chen Y; Ding T; Yao H; Chen L; He X; Xu X
    Int J Clin Exp Pathol; 2014; 7(10):6768-75. PubMed ID: 25400757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct microRNA alterations characterize high- and low-grade bladder cancer.
    Catto JW; Miah S; Owen HC; Bryant H; Myers K; Dudziec E; Larré S; Milo M; Rehman I; Rosario DJ; Di Martino E; Knowles MA; Meuth M; Harris AL; Hamdy FC
    Cancer Res; 2009 Nov; 69(21):8472-81. PubMed ID: 19843843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder.
    Zaravinos A; Volanis D; Lambrou GI; Delakas D; Spandidos DA
    Oncol Rep; 2012 Oct; 28(4):1159-66. PubMed ID: 22895562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
    Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
    Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.
    Cosentino M; Palou J; Gaya JM; Breda A; Rodriguez-Faba O; Villavicencio-Mavrich H
    World J Urol; 2013 Feb; 31(1):141-5. PubMed ID: 22552732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.